Con: are we ready to translate Alzheimer’s disease-modifying therapies to people with down syndrome?
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s13195-014-0061-6
Published Online: 2014-09-12
Published Print: 2014-10
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Head, Elizabeth
Schmitt, Frederick A
License valid from 2014-09-12